Proteomics

Dataset Information

0

Study of reversible oxidation of thiol proteins after hexyl aminolevulinate mediated photodynamic therapy


ABSTRACT: This proteomic study This proteomic study focuses on the role of reversible thiol oxidation after hexyl aminolevulinate mediated PDT (HAL-PDT). The human epidermoid carcinoma cell line A431 was used as model system and red light as light source, a clinical relevant in vitro model. The light dose dependent cell cytotoxicity was measured by resazurin assay. The most clinical relevant dose, LD100, was used for the proteomic part of the study and cells where harvested 30 min after treatment. The reversibly oxidized thiol proteins were selected by biotinylation and identified by mass spectrometry. This proteomic technique revealed over 1100 thiol proteins which were reversibly oxidized after HAL-PDT. Identified proteins were analysed by bioinformatics (IPA and GO) and a list of reliable identified proteins (282 proteins) where further analysed. Both the cellular location and function was determined for these proteins. In addition, 18 of the proteins where identified as redox regulated, 36 to be a part of the apoptotic pathway and 9 to be both redox regulated and a part of apoptotic pathway. From these results we suggest redox regulated proteins as a trigger mechanism for PDT induced apoptosis.focuses on the role of reversible thiol oxidation after hexyl aminolevulinate mediated PDT (HAL-PDT). The human epidermoid carcinoma cell line A431 was used as model system and red light as light source, a clinical relevant in vitro model. The light dose dependent cell cytotoxicity was measured by resazurin assay. The most clinical relevant dose, LD100, was used for the proteomic part of the study and cells where harvested 30 min after treatment. The reversibly oxidized thiol proteins were selected by biotinylation and identified by mass spectrometry. This proteomic technique revealed over 1100 thiol proteins which were reversibly oxidized after HAL-PDT. Identified proteins were analysed by bioinformatics (IPA and GO) and a list of reliable identified proteins (282 proteins) where further analysed. Both the cellular location and function was determined for these proteins. In addition, 18 of the proteins where identified as redox regulated, 36 to be a part of the apoptotic pathway and 9 to be both redox regulated and a part of apoptotic pathway. From these results we suggest redox regulated proteins as a trigger mechanism for PDT induced apoptosis.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Skin

DISEASE(S): Disease Free

SUBMITTER: Animesh Sharma  

LAB HEAD: Geir Slupphaug

PROVIDER: PXD001582 | Pride | 2016-01-12

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
130319_LINDA_GEL1.raw Raw
130319_LINDA_GEL2.raw Raw
130319_LINDA_K1.raw Raw
130319_LINDA_K10.raw Raw
130319_LINDA_K11.raw Raw
Items per page:
1 - 5 of 136
altmetric image

Publications

Photodynamic treatment with hexyl-aminolevulinate mediates reversible thiol oxidation in core oxidative stress signaling proteins.

Helander Linda L   Sharma Animesh A   Krokan Hans E HE   Plaetzer Kristjan K   Krammer Barbara B   Tortik Nicole N   Gederaas Odrun A OA   Slupphaug Geir G   Hagen Lars L  

Molecular bioSystems 20160301 3


Photodynamic therapy (PDT) is a highly selective two-step cancer treatment involving a photosensitizer and illumination with visible light in the presence of molecular oxygen. PDT is clinically approved worldwide for treating several premalignant conditions and cancer forms, especially endoscopically accessible tumors and dermatological malignancies. PDT-mediated cytotoxicity takes place via autophagy, apoptosis and necrosis, but the exact trigger mechanisms for various death-pathways are still  ...[more]

Similar Datasets

2017-04-01 | MSV000080866 | MassIVE
2023-07-21 | PXD043895 | Pride
2018-04-23 | PXD008370 | Pride
2018-04-23 | PXD009038 | Pride
2018-04-23 | PXD008371 | Pride
2011-07-04 | GSE27637 | GEO
2024-01-29 | PXD043914 | Pride
2021-11-17 | PXD029772 |
2022-04-12 | PXD027929 |
2018-06-17 | GSE112997 | GEO